Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis

Biological products for treatment of rheumatoid arthritis usually are cost effective for healthcare systems in Europe, but they are huge financial burden due to the high number of patients and the significant budget impact. The expected saving from introduction on the market of biosimilars are signi...

Descripción completa

Detalles Bibliográficos
Autores principales: Manova, Manoela, Savova, Alexandra, Vasileva, Maria, Terezova, Silvia, Kamusheva, Maria, Grekova, Daniela, Petkova, Valentina, Petrova, Guenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158404/
https://www.ncbi.nlm.nih.gov/pubmed/30294275
http://dx.doi.org/10.3389/fphar.2018.01070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158404/
https://www.ncbi.nlm.nih.gov/pubmed/30294275
http://dx.doi.org/10.3389/fphar.2018.01070

Ejemplares similares